Is it time for Brazil to prioritize TB preventive therapy for all people living with HIV?

Maciel, Ethel L; Prado, Thiago N do; Andrade, Kleydson Bonfim; Golub, Jonathan E

Maciel, Ethel L; Prado, Thiago N do; Andrade, Kleydson Bonfim; Golub, Jonathan E.

Maciel, Ethel L; Universidade Federal do Espírito Santo. Laboratório de Epidemiologia. Vitória. BR
Prado, Thiago N do; Universidade Federal do Espírito Santo. Laboratório de Epidemiologia. Vitória. BR
Andrade, Kleydson Bonfim; Universidade de São Paulo. Faculdade de Saúde Pública. São Paulo. BR
Golub, Jonathan E; Johns Hopkins University. School of Medicine. Center for Tuberculosis Research. Baltimore. US

Braz. j. infect. dis ; 22(1): 74-75, Jan.-feb. 2018.

Article in English | LILACS | ID: biblio-951625

Subject(s)

Humans; Tuberculosis, Pulmonary/prevention & control; HIV Infections/complications; Latent Tuberculosis/prevention & control; Preventive Health Services; Brazil; Isoniazid/therapeutic use; Antitubercular Agents/therapeutic use

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Tuberculosis, Pulmonary / HIV Infections / Latent Tuberculosis Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: Braz. j. infect. dis Journal subject: Communicable Diseases Year: 2018 Type: Article Affiliation country: Brazil / United States Institution/Affiliation country: Johns Hopkins University/US / Universidade Federal do Espírito Santo/BR / Universidade de São Paulo/BR

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google